Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C36H53N7O6 |
Molecular Weight | 679.8493 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=CN=CC=N3)C4CCCCC4)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC5CC5
InChI
InChIKey=BBAWEDCPNXPBQM-GDEBMMAJSA-N
InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1
Molecular Formula | C36H53N7O6 |
Molecular Weight | 679.8493 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:04:26 UTC 2023
by
admin
on
Fri Dec 15 16:04:26 UTC 2023
|
Record UNII |
655M5O3W0U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QJ05AE11
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INCIVO (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
NDF-RT |
N0000182639
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
NCI_THESAURUS |
C783
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
LIVERTOX |
NBK548138
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
WHO-ATC |
J05AP02
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
||
|
WHO-ATC |
J05AE11
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
655M5O3W0U
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
8125
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
SS-135
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
402957-28-2
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
C486464
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
N0000190114
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | Cytochrome P450 3A Inhibitors [MoA] | ||
|
N0000190109
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA] | ||
|
SUB31651
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
N0000182638
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | HCV NS3/4A Protease Inhibitors [MoA] | ||
|
DB05521
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
4173
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
8686
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
C81603
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
DTXSID40193304
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
3010818
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
68595
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
Telaprevir
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
100000124179
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
1102261
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | RxNorm | ||
|
N0000185503
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | P-Glycoprotein Inhibitors [MoA] | ||
|
N0000190107
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA] | ||
|
m10526
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL231813
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY | |||
|
TELAPREVIR
Created by
admin on Fri Dec 15 16:04:26 UTC 2023 , Edited by admin on Fri Dec 15 16:04:26 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
BINDER->LIGAND |
The protein binding is concentration dependent and decreases with increasing telaprevir concentrations at all concentrations of human serum albumin (HSA) and α-1-acid glycoprotein (AAG). In addition, protein binding of telaprevir is affected by the concentration of HSA and AAG.
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE LESS ACTIVE -> PARENT |
Approximately 30-fold less potent than telaprevir.
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
single dose |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||